Precision Antibiotics ApS
Private limited companyCVR 45363171AllerødActive
Precision Antibiotics ApS is a private limited company, based in Allerød, active in research and experimental development on natural sciences and engineering, founded in 2025. The company is new and has been registered for 1 years. The latest net result (2025) was a loss of DKK 981k. 7 people are registered in the company's management and ownership.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Jonas Rosager Henriksen (director, 28/01/2025), Jonas Rosager Henriksen (board member, 26/09/2025) and Anders Elias Hansen (board member, 26/09/2025) (+5).
- Stepped down: Thomas Lars Andresen (board member, 29/04/2026) and Peter Juul Kristensen (chair of the board, 30/04/2026).
- New owners registered: Tla-holding 2010 ApS (26/09/2025), Bastholm-Hansen Holding ApS (26/09/2025) and JHSCI Holding ApS (26/09/2025) (+6).
- No longer registered as owner: Mats Høy Bue (26/09/2025), Tla-holding 2010 ApS (25/09/2025) and Juul Kristensen Holding ApS (26/09/2025) (+2).
Registrations, last 24 months
- 26/09/2025: Share capital changed from 40,000 DKK to 65,600 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −702 | – |
| Operating profit (EBIT) | −1,102 | – |
| Profit before tax | −1,070 | – |
| Net profit | −981 | – |
| Total assets | 39,328 | – |
| Equity | 38,629 | – |
| Liabilities | 698 | – |
| Cash and cash equivalents | 39,080 | – |
| Average number of employees | 2 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 28/01/2025 – 31/12/2025 | 07/07/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,446of 69,742 Better than 2% | No. 3,743of 69,964 Better than 95% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 232of 323 Better than 28% | No. 19of 329 Better than 95% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,208of 16,614 Better than 2% | No. 386of 16,661 Better than 98% |
| All companies of type ApS66,508 companies in the comparison | No. 65,377of 66,379 Better than 2% | No. 2,598of 66,505 Better than 96% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Precision Antibiotics ApS−DKK 702k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Precision Antibiotics ApS−DKK 981k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Precision Antibiotics ApSDKK 38.6m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Precision Antibiotics ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Tla-holding 2010 ApS15%
- Bastholm-Hansen Holding ApS15%
- JHSCI Holding ApS15%
- MSF Family Invest A/S10%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jonas Rosager Henriksen | Director | 28/01/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Jonas Rosager Henriksen | Board member | 26/09/2025 |
| Anders Elias Hansen | Board member | 26/09/2025 |
| Charlotte Vindfeldt | Board member | 26/09/2025 |
| Thomas Lars Andresen | Chair of the board | 30/04/2026 |
| Jens Strathe | Board member | 04/06/2026 |
- Founders
- Mats Høy Bue, Tla-holding 2010 ApS, Juul Kristensen Holding ApS, Bastholm-Hansen Holding ApS, JHSCI Holding ApS
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Thomas Lars Andresen | Board member | 26/09/2025 | 29/04/2026 |
| Peter Juul Kristensen | Chair of the board | 26/09/2025 | 30/04/2026 |
Signing rule: Selskabet tegnes af 2 medlemmer af bestyrelsen i forening eller af et bestyrelsesmedlem sammen med en direktør.
Address and production units
1 active production unitsGravenstensvej 14
3450 Allerød
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Precision Antibiotics ApS | Gravenstensvej 14, 3450 Allerød | 3 | 1031030168 |
Purpose
Selskabets formål er at drive virksomhed med forskning, udvikling og produktion.
The purpose is quoted from the register in Danish.
Changes year by year
27 registered events20265 changesaccounts 1 · management 4
- AccountsAnnual report for 2025 published
- ManagementJens Strathe appointed board member
- ManagementThomas Lars Andresen appointed chair of the board
- ManagementPeter Juul Kristensen stepped down as chair of the board
- ManagementThomas Lars Andresen stepped down as board member
202522 changescapital 1 · management 6 · ownership 14 · founded 1
- CapitalShare capital changed from 40,000 DKK to 65,600 DKK
- ManagementJonas Rosager Henriksen appointed board member
- ManagementThomas Lars Andresen appointed board member
- ManagementCharlotte Vindfeldt appointed board member
- ManagementAnders Elias Hansen appointed board member
- ManagementPeter Juul Kristensen appointed chair of the board
- OwnershipTLA-HOLDING 2010 ApS registered as owner (15%)
- OwnershipBastholm-Hansen Holding ApS registered as owner (15%)
- OwnershipJHSCI Holding ApS registered as owner (15%)
- OwnershipMSF Family Invest A/S registered as owner (10%)
- OwnershipMats Høy Bue is no longer registered as owner
- OwnershipJUUL KRISTENSEN HOLDING ApS is no longer registered as owner
- OwnershipJHSCI Holding ApS is no longer registered as owner
- OwnershipTLA-HOLDING 2010 ApS is no longer registered as owner
- OwnershipBastholm-Hansen Holding ApS is no longer registered as owner
- FoundedRegistered as Precision Antibiotics ApS
- ManagementJonas Rosager Henriksen appointed director
- OwnershipMats Høy Bue registered as owner (5%)
- OwnershipJHSCI Holding ApS registered as owner (25%)
- OwnershipTLA-HOLDING 2010 ApS registered as owner (25%)
- OwnershipJUUL KRISTENSEN HOLDING ApS registered as owner (5%)
- OwnershipBastholm-Hansen Holding ApS registered as owner (25%)
Related companies
Same industry in Allerød
- UNEEG medical A/S38 employees
- KiteX ApS4 employees
- Flow-loop ApS4 employees
- Airlich ApS4 employees
Same people in management
- Vognmandsfirmaet Flemming Paulsen A/Svia Charlotte Vindfeldt
- MedTrace Pharma A/Svia Charlotte Vindfeldt
- FHM Slagtegrise A/Svia Charlotte Vindfeldt
- Commit Biologics ApSvia Thomas Lars Andresen
- Ny Endrupholm Nord A/Svia Charlotte Vindfeldt
- MonTa Biosciences ApSvia Anders Elias Hansen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.